#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14156	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2536	682.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1740	1740	C	884	C	884	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23916	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4083	731.1	0	.	n	.	0	T695C	SNP	695	695	T	1265	1265	C	884	C,T,G	879,4,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23916	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4083	731.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1907	1907	A	967	A	967	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23916	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4083	731.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2541	2541	C	819	C,A,T	817,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23916	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4083	731.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2615	2615	A	792	A,G,T,C	789,1,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23916	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4083	731.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3167	3167	C	829	C,A,G	827,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1908	folP	855	855	100.0	folP.l15.c4.ctg.1	2076	114.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1282	1284	AGC	196;197;197	A;G;C	196;197;197	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4564	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3965	143.6	1	SNP	p	S91F	1	.	.	271	273	TTC	862	864	TTC	151;153;155	T;T;C,A	151;153;154,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4564	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3965	143.6	1	SNP	p	G95N	0	.	.	283	285	GGC	874	876	GGC	153;154;152	G,A;G;C	152,1;154;152	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4564	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3965	143.6	1	SNP	p	D95G	1	.	.	283	285	GGC	874	876	GGC	153;154;152	G,A;G;C	152,1;154;152	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1822	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1812	125.4	1	SNP	p	G45D	0	.	.	133	135	GGC	724	726	GGC	213;212;209	G;G,A;C	213;211,1;209	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	932	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1547	75.2	0	.	n	.	0	A197.	DEL	197	197	A	863	863	A	186	A	186	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4608	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3551	162.1	1	SNP	p	D86N	0	.	.	256	258	GAC	827	829	GAC	165;168;169	G;A;C	165;168;169	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4608	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3551	162.1	1	SNP	p	S87R	1	.	.	259	261	CGT	830	832	CGT	168;166;168	C;G,A;T,G	168;165,1;167,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4608	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3551	162.1	1	SNP	p	R87W	0	.	.	259	261	CGT	830	832	CGT	168;166;168	C;G,A;T,G	168;165,1;167,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4608	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3551	162.1	1	SNP	p	R87I	0	.	.	259	261	CGT	830	832	CGT	168;166;168	C;G,A;T,G	168;165,1;167,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4608	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3551	162.1	1	SNP	p	S88P	0	.	.	262	264	TCC	833	835	TCC	171;170;170	T;C;C	171;170;170	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3802	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3404	139.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1933	1935	GGC	204;203;203	G;G;C	204;203;203	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3752	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2921	160.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1492	1494	GCA	223;223;223	G,T;C;A	222,1;223;223	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3752	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2921	160.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1495	1497	ATC	219;221;221	A;T,C;C,G	219;220,1;220,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3752	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2921	160.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1507	1509	GTG	225;230;228	G,T;T;G,T	224,1;230;227,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3752	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2921	160.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1507	1509	GTG	225;230;228	G,T;T;G,T	224,1;230;227,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3752	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2921	160.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2011	2013	ACC	205;206;209	A,C;C;C	204,1;206;209	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3752	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2921	160.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2065	2067	GCG	214;214;217	G;C;G	214;214;217	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3752	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2921	160.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2065	2067	GCG	214;214;217	G;C;G	214;214;217	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3752	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2921	160.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2188	2190	AGC	185;185;187	A,G;G;C	182,3;185;187	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3752	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2921	160.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2197	2199	GGC	182;180;180	G,A;G;C,A	181,1;180;179,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3752	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2921	160.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2215	2217	CCG	179;180;179	C,T;C;G	178,1;180;179	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5134	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3651	175.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1919	1921	CCG	197;197;195	C,G;C;G	196,1;197;195	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2050	porA	1146	1146	99.91	porA.l6.c17.ctg.1	2332	109.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	797	797	C	145	C	145	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	28;30;30	T;T;A	28;30;30	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	65;65;65	C;A;T	65;65;65	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	65;65;65	A;G;T	65;65;65	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	65;65;66	T;A;C	65;65;66	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	2;2;2	G;A;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	2;2;2	A;T;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	2;1;1	A;G;C	2;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	1;1;1	G;C;C	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	272	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	360	32.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	1;1;1	G;T;T	1;1;1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	V75I	NONSYN	223	225	GTT	643	645	ATT	227;229;228	A,G;T;T	226,1;229;228	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	T89S	NONSYN	265	267	ACC	685	687	AGC	218;220;223	A;G,C;C	218;218,2;223	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	V98I	NONSYN	292	294	GTC	712	714	ATC	194;193;192	A,G;T;C	193,1;193;192	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	.	MULTIPLE	358	359	AA	777	778	CG	190;186	C,G;G,T	189,1;185,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	.	MULTIPLE	361	362	GA	780	782	CAG	190;189;193	C;A;G	189;189;193	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	N122K	NONSYN	364	366	AAC	784	786	AAA	196;197;196	A;A;A	196;197;196	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	811	813	TAT	208;208;207	T;A;T	208;208;207	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	N134E	NONSYN	400	402	AAT	820	822	GAG	212;216;219	G,C;A;G,C	211,1;216;218,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	V135L	NONSYN	403	405	GTG	823	825	CTT	219;219;221	C;T,G;T	219;218,1;221	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	G140K	NONSYN	418	420	GGA	838	840	AAA	221;222;223	A,G;A;A	220,1;222;223	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	847	849	GAA	224;221;221	G;A;A,G	224;221;220,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	A213S	NONSYN	637	639	GCA	1057	1059	TCA	270;274;275	T,A;C;A	268,2;274;275	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	0	.	p	.	0	Y255W	NONSYN	763	765	TAC	1183	1185	TGG	233;232;231	T;G;G,T	233;232;230,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	1	SNP	p	G120K	1	.	.	358	360	AAG	777	779	CGG	190;186;189	C,G;G,T;G,A	189,1;185,1;188,1	porB1b.WHO_X_02194c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	1	SNP	p	A121D	1	.	.	361	363	GAC	780	783	CGC	190;193;193	C;G;C	189;193;193	porB1b.WHO_X_02194c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2666	porB1b	1041	1041	97.41	porB1b.l15.c17.ctg.1	1721	191.1	1	SNP	p	D121N	0	.	.	361	363	GAC	780	783	CGC	190;193;193	C;G;C	189;193;193	porB1b.WHO_X_02194c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9380	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5411	216.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1372	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1753	97.8	1	SNP	p	V57M	0	.	.	169	171	GTG	823	825	GTG	251;252;253	G,A,T;T;G,A	248,2,1;252;252,1	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
